Sol-Gel Technologies Total Long-Term Assets 2016-2024 | SLGL

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Sol-Gel Technologies total long-term assets from 2016 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current

Sol-Gel Technologies Total Long-Term Assets 2016-2024 | SLGL

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Sol-Gel Technologies total long-term assets from 2016 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current

Related Stocks
Company Name	Market Cap
Teva Pharmaceutical Industries (TEVA)	$19.4B
Dr Reddy's Laboratories (RDY)	$11.9B
BridgeBio Pharma (BBIO)	$4.4B
Bausch Health Cos (BHC)	$2.9B
Amphastar Pharmaceuticals (AMPH)	$2.2B
Supernus Pharmaceuticals (SUPN)	$2B
Taysha Gene Therapies (TSHA)	$506M
Personalis (PSNL)	$245M
Assembly Biosciences (ASMB)	$96M
Evoke Pharma (EVOK)	$6M
Teligent (TLGT)	$0M